Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXV9JG
|
||||
Drug Name |
2-(4-chloro-6-(isopentylamino)pyrimidin-2-ylthio)-2-(naphthalen-1-yl)acetic acid
|
||||
Synonyms |
CHEMBL1089317
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C21H22ClN3O2S
|
||||
Canonical SMILES |
CC(C)CCNc1cc(Cl)nc(SC(C(=O)O)c2cccc3ccccc23)n1
|
||||
InChI |
InChI=1S/C21H22ClN3O2S/c1-13(2)10-11-23-18-12-17(22)24-21(25-18)28-19(20(26)27)16-9-5-7-14-6-3-4-8-15(14)16/h3-9,12-13,19H,10-11H2,1-2H3,(H,26,27)(H,23,24,25)
|
||||
InChIKey |
COUZGLSEBNURHL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.